<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113883.3.464.1003.198.12.1132" displayName="Opiate Antagonists" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="HZ90ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Nicotine Replacement"/>            <ns0:Concept code="HZ91ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Methadone Maintenance"/>            <ns0:Concept code="HZ92ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Levo-alpha-acetyl-methadol (LAAM)"/>            <ns0:Concept code="HZ93ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Antabuse"/>            <ns0:Concept code="HZ94ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Naltrexone"/>            <ns0:Concept code="HZ95ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Naloxone"/>            <ns0:Concept code="HZ96ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Clonidine"/>            <ns0:Concept code="HZ97ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Bupropion"/>            <ns0:Concept code="HZ98ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Psychiatric Medication"/>            <ns0:Concept code="HZ99ZZZ" codeSystem="2.16.840.1.113883.6.4" codeSystemName="ICD10PCS" codeSystemVersion="2020" displayName="Pharmacotherapy for Substance Abuse Treatment, Other Replacement Medication"/>        </ns0:ConceptList>        <ns0:Source>National Committee for Quality Assurance</ns0:Source>        <ns0:Purpose>(Clinical Focus: This value set contains concepts to represent treatment of substance abuse with an opioid antagonist medication.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.),(Inclusion Criteria: Includes only relevant concepts associated treatment of substance abuse with an opiate antagonist medication. This is a grouping of ICD10PCS codes.),(Exclusion Criteria: No exclusions.)</ns0:Purpose>        <ns0:Definition>(2.16.840.1.113883.3.464.1003.198.11.1142:Pharmacotherapy)</ns0:Definition>        <ns0:Type>Grouping</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2019-03-15</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>